NeuPath Health Inc. NPTH.V
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 7.05% | -1.30% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.05% | -1.30% | |||
| Cost of Revenue | 6.26% | -1.36% | |||
| Gross Profit | 10.59% | -1.07% | |||
| SG&A Expenses | 8.87% | -25.81% | |||
| Depreciation & Amortization | 6.42% | -1.98% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.58% | -5.23% | |||
| Operating Income | 18.30% | 12,468.00% | |||
| Income Before Tax | 71.72% | 225.86% | |||
| Income Tax Expenses | -1,064.10% | 305.38% | |||
| Earnings from Continuing Operations | 338.51% | 215.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -27.65% | 10.59% | |||
| Net Income | 404.03% | 177.78% | |||
| EBIT | 18.30% | 12,468.00% | |||
| EBITDA | 13.71% | 452.43% | |||
| EPS Basic | 397.56% | 178.85% | |||
| Normalized Basic EPS | 23.91% | 284.00% | |||
| EPS Diluted | 397.56% | 178.85% | |||
| Normalized Diluted EPS | 20.45% | 276.00% | |||
| Average Basic Shares Outstanding | 0.07% | 0.14% | |||
| Average Diluted Shares Outstanding | 1.66% | 5.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||